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AIMS 
The objective of this study was to assess autonomic 
symptoms in subjects with COPD. 
(I) Are autonomic symptoms prevalent in subjects with 
COPD? 
(II) What are the most important clinical correlates of 
autonomic symptoms in subjects with COPD?  
 
 
 
 RESULTS 
Autonomic symptoms were present across all six domains of the 
ASP. These symptoms were mainly associated with high levels of 
anxiety, depression and worsened mental health (p<0.05). The 
presence of severe autonomic symptoms was also associated 
with poor health status and higher levels of fatigue (p<0.05). 
However, there were no correlations between the overall ASP 
scores and demographic or respiratory parameters, except for a 
diminished pupillomotor function that was mildly associated 
with reduced FEV1. 
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Domains 
/Clinical variables   
Orthostatic 
intolerance 
Vasomotor  Secremotor Gastro 
intestinal 
Bladder Papillo-
motor 
Total ASP 
score 
Age               
Height               
Weight               
BMI               
FEV1            0.286*   
FVC                
PEF                
Anxiety     0.448*   0.281*   0.386* 
Depression   0.288* 0.392*       0.391* 
Fatigue     0.318*   0.324* 0.312* 0.300* 
PCS (SF-36)   -0.352*         - 0.358* 
MCS (SF-36) -0.291*     -0.309*     -0.385* 
Dyspnea level               
ASP: autonomic symptom profile 
HADS and SF-36: general health status  
Fatigue: checklist individual strength 
Respiratory outcomes: FEV1, FVC, PEF & dyspnea 
Demographic variables: age, BMI, weight & height 
COPD (n=53, 39♂/14 ♀, Gold II-IV) 
Age:   66±7 years 
Height:  1.68±8.2 meters  
Weight:  74.4±18.5 kilograms 
BMI:   26.1±6.3 Kg/m2 
FEV1 (%predicted): 1.17±0.50 (41.9) 
FVC (%predicted):   2.78±0.84 (81.5) 
PEF (%predicted):   3.65±1.3 (50.2) 
Spearman rho coefficients (significance level: P<0,05) 
SUBJECTS 
OUTCOMES 
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 CONCLUSIONS 
Autonomic complaints are prevalent in subjects with COPD 
especially in those who have higher levels of anxiety, 
depression, fatigue, and poor general health. This highlights the 
need for screening autonomic function in COPD patients who fit 
this profile and their treatment should be adapted accordingly. 
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